Aidoc Wins FDA Clearance for a Single AI Model That Triages 14 Acute Conditions From One CT Scan
For most of the last decade, AI in radiology has meant one algorithm for one problem: a model that flags...
Year: 2026
A 175,000-Woman UK Trial Just Made the Case for Replacing One of Two Radiologists With AI
Britain's breast cancer screening program has long relied on a safeguard considered close to sacred in radiology: every mammogram is...
AI Software Spotted Breast Cancer on Mammograms Up to Six Years Before Diagnosis, Swedish Study Finds
Every mammogram a radiologist reads carries the possibility of a miss — a faint density or asymmetry too subtle to...
The Secretive $1 Billion Biotech Betting Everything on a 4.9 Billion-Parameter ‘Virtual Cell’
When Xaira Therapeutics launched in 2024 with close to $1 billion in funding and a $4 billion valuation, it did...
Tempus AI Swings to Profit, Raises Guidance to $1.6 Billion, and Buys Its Way Into Cancer Blood Tests
For years, Tempus AI has been one of the most closely watched — and most doubted — names in AI-driven...
Nurses, Not Hospital Executives, Are Getting Paid to Study Whether AI Actually Works
Most decisions about which AI tools enter a hospital are made far from the bedside — in boardrooms, procurement offices,...
OpenEvidence Doubles to a $12 Billion Valuation as Doctors Ditch UpToDate for AI Chat
Three years ago, OpenEvidence was an idea sketched out by a former hedge-fund quant and a machine-learning researcher who thought...
Roche Just Moved Its First AI-Found Brain-Disease Target Out of the Lab
Roche and Recursion Pharmaceuticals announced on August 5, 2026 that they have advanced the first drug target to emerge from...
Sanofi Wants AI Agents Doing R&D, Not Just Reading It — Here’s the Five-Year Bet
On June 5, 2026, French drugmaker Sanofi and AI biotech Owkin announced an expanded, multi-year collaboration to build what they...
J&J Just Hired an AI to Design Molecules Its Own Chemists Couldn’t Crack
On January 20, 2026, Isomorphic Labs and Johnson & Johnson's Janssen Biotech unit announced a cross-modality, multi-target research collaboration —...
